|1.||Aleksandrov, V P: 2 articles (05/2003 - 11/2000)|
|2.||Caillon, J: 1 article (07/2015)|
|3.||Poyart, C: 1 article (07/2015)|
|4.||Cattoir, V: 1 article (07/2015)|
|5.||Weber, P: 1 article (07/2015)|
|6.||Ploy, M-C: 1 article (07/2015)|
|7.||Leclercq, R: 1 article (07/2015)|
|8.||Auzou, M: 1 article (07/2015)|
|9.||Medzegue, S: 1 article (06/2015)|
|10.||Elisee-Ndam, M: 1 article (06/2015)|
11/01/1988 - "Josamycin thus attains concentrations in the prostate and seminal vesicles which are effective against Mycoplasma and Chlamydia, pathogens of increasing importance in infections of the urogenital tract. "
03/01/1991 - "It is concluded that josamycin is a safe and effective agent in the treatment of bronchopulmonary infections."
05/01/1985 - "Clinical efficacy and safety of TMS-19-Q.GC tablet (TMS), a new macrolide antibiotic preparation, were compared with those of josamycin (JM) in the treatment of acute odontogenic infection under multicentered double-blind controlled study at the daily dosage of 600 mg of TMS or 1,200 mg of JM. "
01/01/2015 - "genitalium infections, however, no data regarding treatment efficacy with josamycin and resistance in M. "
05/07/2000 - "According to the author, josamycin could be a favourable choice in certain dermatological pathographies and sexually transmitted infections because of its effectiveness and good tolerance."
07/01/2001 - "In this non-inferiority study, the efficacy of a 5-day course of josamycin is comparable to reference treatment in GA beta HS tonsillitis in children."
05/01/1985 - "In order to compare the clinical efficacy and safety of TMS-19-Q.GC tablet (TMS) with josamycin tablet (JM) in acute tonsillitis, the double blind trial was carried out with the daily dosage of 200 mg X 3 in TMS and 400 mg X 3 in JM. "
07/01/2001 - "[Treatment of acute group A beta-hemolytic streptococcal tonsillitis in children with a 5-day course of josamycin]."
11/01/1969 - "[Clinical evaluation of josamycin for the treatment of scarlet fever and hemolytic-streptococcal tonsillitis]."
11/01/1991 - "[A comparative study of the efficacy of josamycin versus oral penicillin in the treatment of acute tonsillitis]."
01/01/2006 - "The results of the treatment were indicative of the josamycin high efficacy in the treatment of the patients with nonsevere community-acquired pneumonia."
01/01/2006 - "[Evaluation of efficacy and safety of josamycin (Vilprafen) in the treatment of patients with community-acquired pneumonia]."
05/01/1993 - "Five-day treatment of non-severe, community-acquired pneumonia with josamycin."
08/15/1989 - "Thirty-five patients with acute pneumonia of bacterial etiology were treated with josamycin at the dose of 2 g/day (adults) or 50 mg/kg/day (children). "
03/04/1989 - "In conclusion, josamycin (1 g/12 h p.o.) is an effective and well tolerated antibiotic for the therapy of pneumonia by M. "
|4.||Respiratory Tract Infections (Respiratory Tract Infection)
07/01/2015 - "The primary objective of our study was to obtain susceptibility data for josamycin against Streptococcus pyogenes isolated from patients presenting with upper respiratory tract infections in France. "
07/01/2015 - "In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract infections in France."
01/01/1983 - "These characteristics represents josamycin for the treatment of respiratory tract infections. "
01/01/1983 - "By virtue of its spectrum of activity josamycin seems to be an ideal antibiotic for the treatment of bacterial respiratory tract infections. "
10/01/1980 - "[Efficacy and tolerance of josamycin in the treatment of acute respiratory infections]."
11/01/1989 - "Josamycin showed in this study to be an effective and safe drug for the treatment of inflammatory acne."
11/01/1989 - "The efficacy of josamycin in the treatment of inflammatory acne has been evaluated in 39 patients. "
11/01/1989 - "[Clinical evaluation of josamycin in the treatment of acne]."
06/01/1988 - "[Josamycin in the treatment of acne vulgaris. "
09/01/1983 - "[Treatment of acne with lose-dose josamycin]."
|10.||Anti-Bacterial Agents (Antibiotics)
|3.||Combination Drug Therapy (Combination Chemotherapy)